DAVID BALTIMORE Insider Trading $AMGN AMGEN INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID BALTIMORE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID BALTIMORE. DAVID BALTIMORE is Director in AMGEN INC ($AMGN) and Director in Immune Design Corp. ($IMDZ) and Director in Regulus Therapeutics Inc. ($RGLS).
DAVID BALTIMORE in AMGEN INC
Trading Symbol: AMGNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID BALTIMORE: Director
Holdings: 32,286 shares
Current Value: $5,385,951
Latest Transaction: May 01 2018
$AMGN Market Capitalization: $124.07B
$AMGN Previous Close: $166.82
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID BALTIMORE in AMGEN INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMGN, IMDZ, RGLS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 01 2018 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,127 | 0 | 32,286 | 31.2 K to 32.3 K (+3.62 %) |
Jun 02 2017 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 153.93 | 3,700 | 569,541 | 31,159 | 34.9 K to 31.2 K (-10.61 %) |
May 03 2017 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,230 | 0 | 34,859 | 33.6 K to 34.9 K (+3.66 %) |
May 05 2016 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,279 | 0 | 33,629 | 32.4 K to 33.6 K (+3.95 %) |
May 03 2016 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 157.21 | 3,312 | 520,684 | 32,350 | 35.7 K to 32.4 K (-9.29 %) |
Mar 31 2016 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 50.44 | 5,000 | 252,200 | 0 | |
Mar 31 2016 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 149.49 | 1,688 | 252,339 | 35,662 | 37.4 K to 35.7 K (-4.52 %) |
Mar 31 2016 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 50.44 | 5,000 | 252,200 | 37,350 | 32.4 K to 37.4 K (+15.46 %) |
Apr 28 2015 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,191 | 0 | 32,350 | 31.2 K to 32.4 K (+3.82 %) |
Mar 03 2015 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 158.76 | 3,647 | 579,011 | 31,159 | 34.8 K to 31.2 K (-10.48 %) |
Feb 23 2015 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 42.13 | 5,000 | 210,650 | 0 | |
Feb 23 2015 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 155.78 | 1,353 | 210,770 | 34,806 | 36.2 K to 34.8 K (-3.74 %) |
Feb 23 2015 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 42.13 | 5,000 | 210,650 | 36,159 | 31.2 K to 36.2 K (+16.05 %) |
Apr 29 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,795 | 0 | 31,159 | 29.4 K to 31.2 K (+6.11 %) |
Feb 26 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 62.55 | 5,000 | 312,750 | 0 | |
Feb 26 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 124.36 | 2,515 | 312,765 | 29,364 | 31.9 K to 29.4 K (-7.89 %) |
Feb 26 2014 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 62.55 | 5,000 | 312,750 | 31,879 | 26.9 K to 31.9 K (+18.60 %) |
Aug 30 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Gift | G | 0.00 | 910 | 0 | 26,879 | 27.8 K to 26.9 K (-3.27 %) |
Aug 30 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 109.66 | 4,582 | 502,462 | 27,789 | 32.4 K to 27.8 K (-14.15 %) |
Apr 30 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,845 | 0 | 32,371 | 30.5 K to 32.4 K (+6.04 %) |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 74.89 | 5,000 | 374,450 | 0 | |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 92.94 | 886 | 82,345 | 30,526 | 31.4 K to 30.5 K (-2.82 %) |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 91.03 | 4,114 | 374,497 | 31,412 | 35.5 K to 31.4 K (-11.58 %) |
Mar 01 2013 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 74.89 | 5,000 | 374,450 | 35,526 | 30.5 K to 35.5 K (+16.38 %) |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 50.78 | 16,000 | 812,480 | 0 | |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 89.00 | 6,800 | 605,220 | 30,526 | 37.3 K to 30.5 K (-18.22 %) |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 88.32 | 9,200 | 812,544 | 37,326 | 46.5 K to 37.3 K (-19.77 %) |
Dec 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 50.78 | 16,000 | 812,480 | 46,526 | 30.5 K to 46.5 K (+52.41 %) |
May 01 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 71.64 | 5,000 | 358,200 | 5,000 | |
May 01 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,395 | 0 | 30,526 | 29.1 K to 30.5 K (+4.79 %) |
Mar 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 58.61 | 5,000 | 293,050 | 0 | |
Mar 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 66.95 | 4,378 | 293,107 | 29,131 | 33.5 K to 29.1 K (-13.07 %) |
Mar 12 2012 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 58.61 | 5,000 | 293,050 | 33,509 | 28.5 K to 33.5 K (+17.54 %) |
Dec 22 2011 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 56.30 | 16,000 | 900,800 | 0 | |
Dec 22 2011 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Payment of Exercise | F | 63.14 | 14,267 | 900,818 | 28,509 | 42.8 K to 28.5 K (-33.35 %) |
Dec 22 2011 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 56.30 | 16,000 | 900,800 | 42,776 | 26.8 K to 42.8 K (+59.76 %) |
Apr 27 2011 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 54.69 | 5,000 | 273,450 | 5,000 | |
Apr 27 2011 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,828 | 0 | 26,776 | 24.9 K to 26.8 K (+7.33 %) |
Apr 28 2010 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 58.43 | 5,000 | 292,150 | 5,000 | |
Apr 28 2010 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,711 | 0 | 24,948 | 23.2 K to 24.9 K (+7.36 %) |
Apr 29 2009 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 50.44 | 5,000 | 252,200 | 5,000 | |
Apr 29 2009 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,982 | 0 | 1,982 | 0 to 2 K |
Dec 08 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 57.23 | 4,837 | 276,822 | 21,255 | 26.1 K to 21.3 K (-18.54 %) |
Dec 08 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 57.38 | 2,400 | 137,712 | 26,092 | 28.5 K to 26.1 K (-8.42 %) |
Dec 08 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 57.40 | 2,900 | 166,460 | 28,492 | 31.4 K to 28.5 K (-9.24 %) |
Dec 08 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 57.41 | 6,000 | 344,460 | 31,392 | 37.4 K to 31.4 K (-16.05 %) |
Dec 08 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 57.42 | 3,863 | 221,813 | 37,392 | 41.3 K to 37.4 K (-9.36 %) |
Dec 08 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 57.48 | 900 | 51,732 | 41,255 | 42.2 K to 41.3 K (-2.13 %) |
Dec 08 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 57.50 | 100 | 5,750 | 42,155 | 42.3 K to 42.2 K (-0.24 %) |
Dec 05 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 29.97 | 30,000 | 899,064 | 0 | |
Dec 05 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 29.97 | 30,000 | 899,064 | 42,255 | 12.3 K to 42.3 K (+244.80 %) |
May 01 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 42.13 | 5,000 | 210,650 | 5,000 | |
May 01 2008 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 2,373 | 0 | 12,255 | 9.9 K to 12.3 K (+24.01 %) |
Apr 30 2007 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 62.55 | 5,000 | 312,750 | 5,000 | |
Apr 30 2007 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,598 | 0 | 9,882 | 8.3 K to 9.9 K (+19.29 %) |
Mar 17 2006 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 74.89 | 5,000 | 374,450 | 5,000 | |
Mar 17 2006 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,335 | 0 | 8,284 | 6.9 K to 8.3 K (+19.21 %) |
Nov 21 2005 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | M | 29.97 | 30,000 | 899,064 | 30,000 | |
Nov 21 2005 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Sell | S | 82.97 | 30,000 | 2,489,100 | 6,949 | 36.9 K to 6.9 K (-81.19 %) |
Nov 21 2005 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Buy | M | 29.97 | 30,000 | 899,064 | 36,949 | 6.9 K to 36.9 K (+431.72 %) |
Mar 16 2005 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 58.61 | 5,000 | 293,050 | 5,000 | |
Mar 16 2005 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,706 | 0 | 1,706 | 0 to 1.7 K |
Mar 16 2004 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Option Exercise | A | 59.48 | 5,000 | 297,400 | 5,000 | |
Mar 16 2004 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,643 | 0 | 1,643 | 0 to 1.6 K |
Page: 1